Default antiplatelet choice by access route for NSTEMI PCI
| All (%) | Femoral (%) | Radial (%) | Radial+ (%) | |
|---|---|---|---|---|
| Clopidogrel | 52.4 | 60.0 | 50.3 | 50.2 |
| Prasugrel | 1.9 | 5.0 | 1.3 | 0.0 |
| Ticagrelor | 27.8 | 25.0 | 29.3 | 34 |
| Tailored | 16.5 | 10.0 | 18.5 | 20.8 |
| Tailored or ticagrelor | 45.3 | 35.0 | 47.8 | 54.8* |
*p<0.01 for trend across groups.
NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention.